Myelodysplastic–myeloproliferative diseases

Myelodysplastic-myeloproliferative diseases
Myelodysplastic-myeloproliferative diseases
Specialty	Hematology

Myelodysplastic–myeloproliferative diseases are a category of hematological malignancies which have characteristics of both myelodysplastic and myeloproliferative conditions.^[1]

When a hematological malignancy is characterised by normal differentiation of cells of myeloid cell line, it is referred to as myeloproliferative. On the other hand, when there is abnormal differentiation of cells of myeloid cell line, it is referred to as myelodysplastic.^{[citation needed]}

References edit

^ "Myelodysplastic/myeloproliferative disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 11 July 2019.

External links edit

http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/Patient

This oncology article is a stub. You can help Wikipedia by expanding it.

[1] "Myelodysplastic/myeloproliferative disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 11 July 2019.

[1]